Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: A population-based study

by biblioteca on 12 d'abril de 2021 with No hi ha comentaris

Julián, M. T., Pera, G., Soldevila, B., Caballería, L., Julve, J., Puig-Jové, C., Mauricio, D., . . . Alonso, N. (2021). Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: A population-based study. European Journal of Endocrinology, 184(4), 587-596. https://doi.org/10.1530/EJE-20-1240